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Objective To develop a sepsis care bundle for the initial
management of maternal sepsis in low resource settings.
Design Modified Delphi process.
Setting Participants from 34 countries.
Population Healthcare practitioners working in low resource settings
(n = 143; 34 countries), members of an expert panel (n = 11) and
consultation with theWorld Health Organization Global Maternal
and Neonatal Sepsis Initiative technical working group.
Methods We reviewed the literature to identify all potential
interventions and practices around the initial management of
sepsis that could be bundled together. A modified Delphi process,
using an online questionnaire and in-person meetings, was then
undertaken to gain consensus on bundle items. Participants
ranked potential bundle items in terms of perceived importance
and feasibility, considering their use in both hospitals and health
centres. Findings from the healthcare practitioners were then
triangulated with those of the experts.
Main outcome measure Consensus on bundle items.
Results Consensus was reached after three consultation rounds,
with the same items deemed most important and feasible by both
the healthcare practitioners and expert panel. Final bundle items
selected were: (1) Fluids, (2) Antibiotics, (3) Source identification
and control, (4) Transfer (to appropriate higher-level care) and
(5) Monitoring (of both mother and neonate as appropriate). The
bundle was given the acronym ‘FAST-M’.
Conclusion A clinically relevant maternal sepsis care bundle for low
resource settings has been developed by international consensus.
Keywords care bundle, Delphi process, low resource setting,
maternal sepsis.
Tweetable abstract A maternal sepsis care bundle for low resource
settings has been developed by international consensus.
Linked article: This article is commented on byOkonofua. To view
thismini commentary visit https://doi.org/10.1111/1471-0528.16029.
Please cite this paper as: Lissauer D, Cheshire J, Dunlop C, Taki F, Wilson A, Smith JM, Daniels R, Kissoon N, Malata A, Chirwa T, Lwesha VM, Mhango
C, Mhango E, Makwenda C, Banda L, Munthali L, Nambiar B, Hussein J, Williams HM, Devall AJ, Gallos I, Merriel A, Bonet M, Souza JP, Coomarasamy
A. Development of the FAST-M maternal sepsis care bundle for use in low resource settings: a modified Delphi process. BJOG 2019; https://doi.org/10.1111/
1471-0528.16005.
1ª 2019 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
DOI: 10.1111/1471-0528.16005
www.bjog.org
Introduction
Maternal sepsis is defined as ‘organ dysfunction resulting from
infection during pregnancy, childbirth, post-abortion, or the
post-partum period’.1 It is the third most common direct cause
of maternal mortality, accounting for 11% of maternal deaths
worldwide and disproportionately affecting low- and middle-
income countries (LMICs).2 In 2013, the WHO estimated that
99% of the 302 000 maternal deaths had occurred in LMICs.3
Until now, attempts to address Sustainable Development
Goal 3.1 of reducing global maternal mortality ratio to less
than 70 per 100 000 live births4 have often focused on
haemorrhage and hypertensive disorders, with maternal sep-
sis receiving less attention.5
The World Health Assembly has recognised sepsis as a glo-
bal health priority and has adopted a resolution to improve
the prevention, detection and management of sepsis.6 As part
of the effort to address this and in recognition that only
modest inroads have been made in decreasing the burden
and poor outcomes of maternal and neonatal sepsis, the
World Health Organization (WHO) and Jhpiego launched
the ‘Global Maternal and Neonatal Sepsis Initiative’ with an
objective to develop and test effective strategies to prevent,
detect and successfully manage maternal and neonatal sepsis.
Development of an internationally recognised maternal sep-
sis care bundle is a key step in this strategy.5
Care bundles are a set of evidence-based practices, generally
three to five items, that when performed collectively and reliably,
improve patient outcomes.7 Compliance with a bundled
approach to sepsis management has been demonstrated to
reduce mortality,8,9 and have been a cornerstone of sepsis
improvement initiatives in high-income settings.8–12 Most
notably, implementation of the Surviving Sepsis Campaign’s
bundle has been associated with a reduction in mortality.12,13
Despite this, there are no internationally recognised sepsis care
bundles that are specific to the maternal population and can be
implemented in a low-resource setting.14–16 A continent-wide
survey in Africa15 revealed that only 1.5% (n = 4/263) of
healthcare facilities surveyed could implement the SSC guideli-
nes in their entirety. The inability reliably to implement recom-
mended sepsis management strategies within a low-resource
setting highlights the need for a new approach. The develop-
ment of a maternal sepsis bundle for low-resource settings has
been identified as an international ‘Priority Action’.5,17
Our work aimed to carry out this directive by developing
a maternal sepsis care bundle for the initial management of
maternal sepsis in low resource settings.
Methods
Selection of items to include in the Delphi
A comprehensive list of potential treatment and monitoring
items was obtained for consideration in the consensus
process. National and international guidelines, as well as
relevant articles, were reviewed until saturation was
achieved (Appendix S1). We screened 217 items for potential
inclusion, removed duplicates and grouped similar items. A
list of 41 items was then shared with an advisory panel of
experts in global health and sepsis comprising doctors and
academics working in the fields of obstetrics, neonatology,
and anaesthetics. Three items – immunoglobulin therapy,
vasopressors and central venous monitoring – were deemed
too infeasible to implement in a low resource and were
excluded prior to the Delphi process. A final list of 38 items
was developed into an online questionnaire (Appendix S2).
Modified Delphi process
To develop a care bundle for the initial management of
maternal sepsis in low resource settings, we sought to form
a consensus by eliciting the views of both healthcare practi-
tioners and experts within maternal and perinatal care.
The consensus process incorporated a modified three-
step Delphi process,18 which took place between December
2015 and May 2016. Figure 1 illustrates the modified
Delphi process.
During the first round, an online questionnaire was dis-
tributed to healthcare practitioners only. Eligible partici-
pants were either those currently working in LMICs or
those who had prior experience of working with mothers
with sepsis in LMICs. Countries were considered to be low
resource if they met the World Bank Classification19 of
low- or lower-middle-income countries. Suitable healthcare
practitioners were identified through professional networks,
literature reviews, and online searches, and were recruited
by email from a range of healthcare settings.
In the second round, the same questionnaire was dis-
tributed to the expert panel to triangulate against the
responses from the healthcare practitioners. The expert
group consisted of international experts within the field of
global health, sepsis, and obstetrics. An effort was made to
ensure that a range of expertise was included. Group mem-
bers were contacted by email and invited to take part in
the same manner as the healthcare practitioners. Results
from round one were not revealed to the expert panel.
Participants who consented to be involved were sent a
link to an online questionnaire (Appendix S2) to complete.
The questionnaire was in English. Initial screening ques-
tions ascertained the participant’s role and clinical experi-
ence of managing sepsis. Participants were asked to rate
potential bundle items, which included both treatment and
monitoring components. Likert scales were used to score
all potential items in terms both of their importance in the
immediate management of maternal sepsis (within 3 hours)
and feasibility to be adopted both within a health centre
and hospital setting of a low-or lower-middle-income
country. Questions relating to importance were scored 1–5
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on the Likert scale, with ‘1’ being very un-important and
‘5’ being very important. Questions relating to feasibility
were scored 1–4, where ‘1’ was definitely un-feasible and
‘4’ was definitely feasible. Spaces for free text were included
to enable participants to suggest any additional items they
felt should be included. No incentive was offered for com-
pleting the questionnaire.
Following the second round, preliminary results from
the Delphi process were presented to the WHO Global
Maternal and Neonatal Sepsis Initiative technical working
group. This was not a formal round of the Delphi process
but was an additional opportunity to gather expert opinion
and seek suggestions.
In the final round, the results of the responses from the
first two rounds were re-distributed to both the healthcare
practitioners and expert panel, along with a final list of
bundle items. The final list of treatment items presented
was limited to five items, in line with the recommended
number of components of a care bundle.7 An online ques-
tionnaire (Appendix S3) sought to determine consensus on
these finalised bundle items.
Following completion of the modified Delphi process, a
bundle implementation workshop, attended by policymak-
ers and practitioners (21 participants), was conducted in
Lilongwe, Malawi. This site was chosen as it was planned
as the site for future feasibility testing. The purpose of this
Bundle implementation workshop was to conclude the con-
sensus-forming process with a wide range of stakeholders
and to discuss methods for the implementation and evalua-
tion of the maternal sepsis bundle. The final components
of the bundle were presented and further feedback sought.
Role of the funding source
Research funding was provided by University of Birming-
ham and the charity Ammalife. Several authors are, or have
recently been, employed by the University of Birmingham.
D.L., A.C., J.C., and C.D. all work with the charity Ammal-
ife as volunteers. Those engaged in the work were excluded
from the funding decision-making by Ammalife. Neither
funder had input into the study design, data collection,
data analysis, data interpretation or writing of the report.
Results
Overall 154 participants from 34 LMICs (Africa: 92/143
[64%], Asia: 22/143 [15%], Europe: 17/143 [12%], South
America: 11/143 [8%] and North America: 1/143 [1%])
participated in the Delphi process. The practitioner panel
included 143 members from speciality 81/143 (57%) and
non-speciality 7/143 (5%) physicians, midwives, and nurses
12/143 (8%), non-physician clinicians 27/143 (19%), clini-
cal scientists 6/143 (4%) and ‘other’ 10/143 (7%), working
in a range of settings (tertiary care: 64/143 [45%], district
hospital: 56/143 [39%], health centres: 12/143 [8%] and
other: 11/143 [8%]). When asked about their experience in
managing maternal sepsis, 110/143 (77%) responded that
Figure 1. Flowchart depicting the modified Delphi process used to derive the treatment and monitoring components of the FAST-M maternal sepsis
bundle.
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they had managed a case of maternal sepsis in the preced-
ing 6 months. The expert panel consisted of 11 members,
including six obstetricians, one paediatric intensivist, one
infectious disease physician, and one emergency medicine
physician; two members were senior global maternal health
academics. All members of the expert panel had experience
in implementing international health quality improvement
projects in the fields of sepsis and maternal health.
The first round of the Delphi process ranked potential
bundle items by clinical importance and implementation
feasibility, in both a hospital and health centre setting (Fig-
ure 2A–D). The treatment item perceived to be most
important by the highest number of respondents was early
administration of antibiotics; 138/143 (97%) of healthcare
practitioners rated it ‘very important’. Additional items fre-
quently ranked as important or very important included:
Figure 2. Perceived importance and feasibility of treatment and monitoring items in both a hospital and health centre setting.
4 ª 2019 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists
Lissauer et al.
obtaining venous access 131/143 (92%), administering
intravenous fluid 118/143 (83%), identifying and treating
the underlying source of infection 100/143 (70%), and
ensuring appropriate location for care 90/143 (63%) (Fig-
ure S1). In terms of feasibility, the following treatment
items were deemed the most feasible to implement in a health
centre setting; antipyretics 103/143 (72%), obtaining venous
access 103/143 (72%), administration of intravenous fluids
102/143 (71%), early administration of antibiotics 94/143
(66%), and correct positioning of the patient 94/143 (66%)
(Figure S2). The overall feasibility of implementing these
items was higher in the hospital setting (Figure S3).
The monitoring items perceived to be most important by
the highest number of respondents were measurement of the
patient’s blood pressure 129/143 (90%) along with measure-
ment of the patient’s respiratory rate and heart rate 128/143
(90%). Additional items frequently ranked as very important
included: measurement of urine output by catheter,118/143
(83%); assessment of consciousness level, 116/143 (81%);
measurement of temperature, 108/143 (76%), and monitor-
ing of the newborn, if applicable, 99/143 (69%) (Figure S4).
Monitoring items deemed most feasible to implement in a
health centre setting were measurement of blood pressure,
114/143 (80%); measurement of temperature, 114/143
(80%); measurement of respiratory rate and heart rate,
113/143 (79%); assessment of consciousness level, 100/143
(70%); malaria testing, 82/143 (57%); measurement of capil-
lary refill, 80/143 (56%); rapid HIV test, 79/143 (55%); and
measurement of urine output by catheter, 79/143 (55%)
(Figure S5). Similarly, in a hospital setting these items were
also deemed most feasible, although measurement of urine
output by catheter was perceived to be more feasible than in
the health centre setting (122/143, 85% versus 79/143, 55%)
(Figure S6).
The second round of the Delphi process asked the expert
panel to rate the importance of potential bundle items, in
both a hospital and health centre setting (Figures S7 and
S8). The results of the expert panel were consistent with
those of the practitioner panel, rating the same components
as being the most important in the immediate treatment of
maternal sepsis and in the initial monitoring of women
with maternal sepsis (Table 1).
Observations made at the WHO Global Maternal and
Neonatal Sepsis Initiative technical working group consul-
tation, after reviewing the first two rounds of the Delphi
process, were that resource availability varied widely among
healthcare facilities within low-resource settings and the
proposed bundle should be implementable across the var-
ied settings. Furthermore, it was noted that although the
assumption had been made that the measurement of oxy-
gen saturations was not sufficiently feasible to warrant
inclusion in a bundle, consideration must be given to the
fact that in some healthcare settings it will be available.
All participants from rounds one and two were invited
to take part in the third round of the Delphi process. Of
these, a total of 66 participants participated: 57 of the
healthcare practitioners and nine members of the expert
panel. Good agreement was achieved with all but two
healthcare practitioners, with 55/57 (97%) agreeing with
the final treatment components and 56/57 (98%) of health-
care practitioners agreeing with the final selection of moni-
toring components for inclusion. All members of the
expert panel agreed with the final treatment and monitor-
ing components.
Based on this Delphi process, the final bundle was devel-
oped to incorporate the following items: Fluids, Antibiotics,
Source identification and control, Transfer to an appropriate
level of care, and ongoing Monitoring of mother and neo-
nate. Intravenous access was removed from the final bundle,
as it was a prerequisite to administering intravenous antibi-
otics and fluids rather than an individual key component. To
aid practitioner recall, the bundle was given the acronym
Table 1. Most important treatment and monitoring items as ranked
by the practitioner and expert panels according to their mean score
on the 5-point Likert scale
Practitioner panel Rank Expert panel
Treatment items
Antibiotics
Mean = 4.90, SD = 0.58
1 Antibiotics
Mean = 5.00, SD = 0.00
Intravenous access
Mean = 4.83, SD = 0.69
2 Intravenous access
Mean = 5.00, SD = 0.00
Intravenous fluids
Mean = 4.71, SD = 0.76
3 Intravenous fluids
Mean = 4.64, SD = 0.48
Source identification and
control
Mean = 4.56, SD = 0.82
4 Location
Mean = 4.36, SD = 0.64
Location
Mean = 4.39, SD = 0.97
5 Source identification and
control
Mean = 4.09, SD = 1.16
Monitoring items
Blood pressure
Mean = 4.85, SD = 0.58
1 Respiratory rate and heart
rate
Mean = 4.82, SD = 0.39
Respiratory rate and heart rate
Mean = 4.80, SD = 0.70
2 Conscious level
Mean = 4.82, SD = 0.39
Urine output
Mean = 4.73, SD = 0.69
3 Urine output
Mean = 4.64, SD = 0.48
Conscious level
Mean = 4.71, SD = 0.71
4 Monitoring of baby
Mean = 4.64, SD = 0.48
Temperature
Mean = 4.65, SD = 0.75
5 Blood pressure
Mean = 4.55, SD = 0.66
Monitoring of baby
Mean = 4.46, SD = 0.94
6 Temperature
Mean = 4.27, SD = 0.96
Oxygen saturations
Mean = 4.38, SD = 1.00
7 Oxygen saturations
Mean = 4.27, SD = 0.96
SD, standard deviation.
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‘FAST-M’. The seven monitoring items agreed upon in the
Delphi process constituted the monitoring component of the
FAST-M bundle.
The results of the Delphi process were presented at the
bundle implementation workshop, at which further agree-
ment on the FAST-M bundle items was achieved.
Discussion
Main findings
An evidence-informed and consensus-driven modified
Delphi process was conducted to develop the first mater-
nity-specific sepsis care bundle for use in low-resource
settings. The final items included in the bundle were fluids,
antibiotics, source identification and control, transport and
monitoring. This has been abbreviated to the acronym
FAST-M for ease of practitioner recall.
Strengths and limitations
Strengths of our approach include that we derived consen-
sus from a large number of healthcare practitioners and
subject experts, who were familiar with working in a range
of low-resource settings. This included representation from
Africa, South America, and Asia. Triangulating the
responses of the healthcare practitioners with that of an
expert panel enabled us to validate the findings between
these groups. Despite the range of perspectives, consensus
was rapidly reached within three rounds, with high levels
of agreement within both the expert panel and the health-
care practitioner panel.
Identification of the majority of the healthcare practi-
tioner panel relied upon stakeholders cascading the invita-
tion to fellow eligible colleagues and therefore may not be
representative of all practitioners in that setting. In particu-
lar, most practitioners were employed by larger health facil-
ities. Additionally we have not defined what the neonatal
monitoring and subsequent treatment should be; however,
work is underway to address this separately.
Interpretation
In our Delphi, lactate, blood cultures and oxygen therapy
were mostly perceived as being of reasonable importance;
however, the feasibility of reliably implementing these items
in low-resource settings limited their usefulness as bundle
elements. This is consistent with the reported scarcity of the
required resources to measure lactate, test blood cultures or
reliably deliver oxygen therapy in resource-poor settings.16
Although monitoring a patient’s oxygen saturations was
perceived as very important by both the healthcare practi-
tioner and expert panel, the inability of many facilities in
low-resource settings to measure oxygen saturations means
that this item will not be applicable in many settings. Mon-
itoring of oxygen saturations was not considered always
feasible, but its monitoring should be advocated in facilities
where it is feasible to do so; this advice is consistent with
other current recommendations, in which oxygen therapy
is not suggested to be a universal requirement for sepsis
care,10,20 but is recommended to be applied to patients
with inadequate oxygen saturation.21
There have been previous attempts to develop sepsis care
bundles for low-resource settings, though they are not
widely used or optimised for the obstetric population
(Table 2). D€unser et al.22 collaborated with a global work-
ing group in intensive care to develop recommendations
for sepsis care in low-resource settings. Development of
two suggested care bundles followed, with an ‘acute care
bundle’ comprising oxygen therapy, fluid resuscitation,
early and adequate antimicrobial therapy and surgical
source control, and a ‘post-acute care bundle’ consisting of
re-evaluation of antimicrobial therapy, deep vein thrombo-
sis prophylaxis, glucose control and weaning of invasive
support.22 Our FAST-M maternal sepsis bundle should be
considered an acute phase bundle.
We note that the final components of the FAST-M bun-
dle are consistent with those of D€unser et al.’s22 acute care
bundle, except for the exclusion of oxygen therapy, and the
inclusion of maternal and fetal or neonatal monitoring.
Table 2. Comparison of monitoring and treatment items included
in the FAST-M maternal sepsis care bundle with existing sepsis
bundles
Surviving
Sepsis
Campaign’s
resuscitation
bundle10
UK
Sepsis
Trust’s
Sepsis
Six
bundle11
D€unser
et al.
Acute
care
bundle22
FAST-M
maternal
sepsis
bundle
Lactate X X
Blood culture X X
Antibiotics X X X X
Fluids X X X X
Oxygen X X
Urine output* X X
Monitoring of
mother
X
Monitoring of
neonate
X
Source
identification
and control
X X
Transfer to
higher
level care
X
*Urine output monitoring is a requirement of the monitoring
component of the FAST-M maternal sepsis care bundle.
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Inclusion of neonatal monitoring in our bundle is unique
and important given that maternal infection is a major risk
factor for early-onset neonatal infection.23 Maternal illness
mandates the need for additional care of the neonate, as
critical illness in the mother often contributes to increased
morbidity and mortality in the neonate.24–26
Sepsis strategies for use in low-resource settings must be
simple to implement, considerate of local resources and
available personnel. When developing this bundle for low-
resource settings, we considered not only the importance
but also the feasibility of implementing each item. To max-
imise effectiveness, all components of the FAST-M bundle
must be completed promptly in every patient. If any ele-
ment of the FAST-M bundle cannot be addressed at a par-
ticular facility, the patient should be transferred to an
appropriate setting that can complete the remaining bundle
components. Use of the FAST-M bundle, in its intended
setting, will need practical and timely triggers. For example,
using deranged maternal vital signs rather than relying on
evidence of haematological and biochemical derangement,
which are unlikely to be available at these facilities. Unlike
many approaches in high-resource settings, a wide range of
healthcare practitioners in both a health centre and hospital
setting can implement all elements of the FAST-M bundle.
This is particularly important when considering the time-
sensitive nature of sepsis management and lack of critical
care facilities.
Having developed a maternal sepsis bundle for low-
resource settings, we recommend that a suitable implemen-
tation approach and the required implementation tools be
developed. Such an implementation approach should focus
on improving healthcare practitioner’s awareness of the
time-critical nature of maternal sepsis in addition to devel-
oping tools to improve its early recognition. We further
recommend that the effectiveness of the bundle be evalu-
ated in the clinical setting for which it was developed.
Although seeking to validate and test the bundle clinically
was beyond the scope of this paper, a multicentre feasibility
study assessing whether the introduction of the FAST-M
maternal sepsis bundle is possible in a low-resource setting
is currently taking place (ISRCTN 87339737). If deemed
feasible, a definitive trial to determine the ability of FAST-
M to reduce maternal mortality and severe morbidity is
recommended.
Conclusion
We describe the process by which a care bundle for the ini-
tial management of maternal sepsis in low-resource settings
has been developed using a consensus-forming modified
Delphi process. Engagement of a large number of health-
care practitioners from a wide range of countries, and an
expert panel, has ensured the development of a clinically
relevant care bundle for the immediate management of
maternal sepsis in low-resource settings.
Disclosure of interests
Dr Daniels undertakes consultancy work in addition to his
voluntary work for the registered charity UK Sepsis Trust.
The charity receives public and philanthropic funds. The
other authors declare no competing interests. Completed
disclosure of interest forms are available to view online as
supporting information.
Contribution to authorship
DL, AC, FT, AW, HMW, and AJD conceived the research
project. DL, FT, AW, JMS, RD, NK, AM, TC, VML, CM,
EM, CM, LB, LM, BN, JH, AM, MB, JPS, and AC partici-
pated in the data collection. FT analysed the data. FT, AW,
DL, JC, IG, and CD interpreted the findings. JC, DL, and
CD wrote the first draft, revised subsequent drafts, and pre-
pared the manuscript. All authors contributed equally to
the revision of the manuscript and approved the final ver-
sion of the paper. JC coordinated the contributors.
Details of ethics approval
Ethics approval to undertake this work was granted by the
University of Birmingham’s research ethics team (ERN_16-
1168; date of approval 22 October 2015).
Funding
University of Birmingham (RG_16-150) and Ammalife
(1120236).
Supporting Information
Additional supporting information may be found online in
the Supporting Information section at the end of the arti-
cle.
Figure S1. Perceived importance of treatment items by
healthcare practitioner panel.
Figure S2. Perceived feasibility of treatment items in a
health centre setting by healthcare practitioner panel.
Figure S3. Perceived feasibility of treatment items in a
hospital setting by healthcare practitioner panel.
Figure S4. Perceived importance of monitoring items by
healthcare practitioner panel.
Figure S5. Perceived feasibility of monitoring items in a
health centre setting by healthcare practitioner panel.
Figure S6. Perceived feasibility of monitoring items in a
hospital setting by healthcare practitioner panel..
Figure S7. Perceived importance of treatment items by
expert panel.
Figure S8. Perceived importance of monitoring items by
expert panel.
7ª 2019 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists
Development of the FAST-M maternal sepsis bundle
Appendix S1. List of international guidance, national
guidelines and original articles used to identify treatment
and monitoring items for inclusion in the modified Delphi
process.
Appendix S2. Questionnaire used in rounds one and
two of the Delphi study.
Appendix S3. Questionnaire used in round three of the
Delphi study. &
References
1 Bonet M, Pileggi V, Rijken MJ, Coomarasamy A, Lissauer D, Souza
JP, et al. Towards a consensus definition of maternal sepsis: results
of a systematic review and expert consultation. Reprod Health
2017;14:67.
2 Say L, Chou D, Gemmill A, Tuncalp €O, Moller A-B, Daniels J, et al.
Global causes of maternal death: a WHO systematic analysis. Lancet
Glob Health 2014;2:e323–33.
3 World Health Organization. Trends in Maternal Mortality: 1990 to
2015; estimates by WHO, UNICEF, UNFPA, World Bank Group and
the United Nations Population Division. Geneva: WHO; 2015.
4 World Health Organization. SDG 3: Ensure healthy lives and
promote wellbeing for all at all ages. Sustainable development goals
[Internet]. 2017 [www.who.int/sdg/targets/en/]. Accessed 1 October
2018.
5 World Health Organization. Statement on Maternal Sepsis. Human
Reproduction Programme. Geneva: WHO; 2017.
6 Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer
S. Recognizing sepsis as a global health priority—a WHO resolution.
N Engl J Med 2017;377:414–7.
7 Institute for Healthcare Improvement. Evidence-based care bundles
[Internet]. [www.ihi.org/Topics/Bundles/Pages/default.aspx]. Accessed
12 February 2019.
8 Damiani E, Donati A, Serafini G, Rinaldi L, Adrario E, Pelaia P, et al.
Effect of performance improvement programs on compliance with
sepsis bundles and mortality: a systematic review and meta-analysis
of observational studies. PLoS ONE 2015;10:e0125827.
9 Barochia AV, Cui X, Vitberg D, Suffredini AF, O’Grady NP, Banks
SM, et al. Bundled care for septic shock: an analysis of clinical trials.
Crit Care Med 2010;38:668–78.
10 Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R,
et al. Surviving Sepsis Campaign: international guidelines for
management of sepsis and septic shock: 2016. Intensive Care Med
2017;43:304–77.
11 Robson WP, Daniel R. The sepsis six: helping patients to survive
sepsis. Br J Nurs 2008;17:16–21.
12 Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall
JC, Bion J, et al. The Surviving Sepsis Campaign: results of an
international guideline-based performance improvement program
targeting severe sepsis. Crit Care Med 2010;38:367–74.
13 Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ,
Phillips GS, et al. Time to treatment and mortality during mandated
emergency care for sepsis. N Engl J Med 2017;376:2235–44.
14 Bataar O, Lundeg G, Tsenddorj G, Jochberger S, Grander W, Baelani
I, et al. Nationwide survey on resource availability for implementing
current sepsis guidelines in Mongolia. Bull World Health Organ
2010;88:839–46.
15 Baelani I, Jochberger S, Laimer T, Otieno D, Kabutu J, Wilson I,
et al. Availability of critical care resources to treat patients with
severe sepsis or septic shock in Africa: a self-reported, continent-
wide survey of anaesthesia providers. Crit Care 2011;15:R10.
16 Abdu M, Wilson A, Mhango C, Taki F, Coomarasamy A, Lissauer D.
Resource availability for the management of maternal sepsis in
Malawi, other low-income countries, and lower-middle-income
countries. Int J Gynecol Obstet 2018;140:175–83.
17 Jhpiego. Enhancing the Focus on Maternal Infection: Report of a
Consultative Meeting. Baltimore: Jhpiego; 2015.
18 Dalkey N, Helmer O. An experimental application of the DELPHI
method to the use of experts. Manage Sci 1963;9:458–67.
19 The World Bank. Data: World Bank Country and Lending Groups
[Internet]. [https://datahelpdesk.worldbank.org/knowledgebase/artic
les/906519-world-bank-country-and-lending-groups]. Accessed 12
February 2019.
20 Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign
bundle: 2018 update. Intensive Care Med 2018;46:997–1000.
21 National Institute for Health and Care Excellence (NICE). Sepsis:
Recognition, Assessment and Early Management. London: NICE; 2016.
22 D€unser MW, Festic E, Dondorp A, Kissoon N, Ganbat T, Kwizera A,
et al. Recommendations for sepsis management in resource-limited
settings. Intensive Care Med 2012;38:557–74.
23 National Institute for Health and Care Excellence (NICE). Neonatal
Infection (Early Onset): Antibiotics for Prevention and Treatment
(CG149). London: NICE; 2012.
24 Bhutta ZA, Lassi ZS, Blanc A, Donnay F. Linkages among
reproductive health, maternal health, and perinatal outcomes. Semin
Perinatol 2010;34:434–45.
25 Ronsmans C, Chowdhury ME, Dasgupta SK, Ahmed A, Koblinsky M.
Effect of parent’s death on child survival in rural Bangladesh: a
cohort study. Lancet 2010;375:2024–31.
26 Anderson FWJ, Morton SU, Naik S, Gebrian B. Maternal mortality
and the consequences on infant and child survival in rural Haiti.
Matern Child Health J 2007;11:395–401.
8 ª 2019 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists
Lissauer et al.
